Drug Controller General of India: Current Affairs, GK & News - 2020-2021

First indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine Approved by DCGI

Published: July 15, 2020

The first-ever completely home-grown Pneumococcal Polysaccharide Conjugate Vaccine has been approved by the Drug Controller General of India. The vaccine has been developed by Serum Institute of India, Pune. Serum Institute of India is also involved in the development of COVID 19 vaccine. The DCGI had given approval earlier to Serum Institute of India to ..

Month: 

Category: 

Topics: 

Indigenously Developed ‘COVAXIN’ gets DCGI approval for Human Clinical Trials

Published: June 30, 2020

The Drug Controller General of India (DCGI) has given approval for Phase I and Phase II human clinical trials for COVID-19 vaccine ‘COVAXIN’. In association with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), COVAXIN is developed by Hyderabad based vaccine & bio-therapeutics manufacturer-Bharat Biotech.  At NIV Pune, the ..

Month: 

Category: 

Topics: 

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

Published: June 22, 2020

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals were granted approval by the Drug Controller General of India for the production and marketing ..

Month: 

Category: 

Topics: 

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

Published: June 22, 2020

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic ..

Month: 

Category: 

Topics: 

ICMR recommends hydroxy-chloroquine for high-risk coronavirus cases

Published: March 25, 2020

The national task force for COVID-19 constituted by Indian Council for Medical Research (ICMR) has recommended hydroxy-chloroquine as a preventive drug for high-risk cases, who are infected by coronavirus. The medication should be given to the asymptomatic healthcare workers, who are under high risk by serving the infected patients. It is also recommended to asymptomatic ..

Topics: 

Advertisement